Intrinsiqs

Is Organon & Co. overvalued?

Organon & Co. (OGN) — key valuation metrics and fundamentals.

No verdict
Price
$13.72
Fair value
—
Current P/E
—
Normal P/E
4.4
Market cap
$3.60B
Dividend yield
0.6%
Return on equity
23.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares OGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.